Dr. Deepak Srivastava and the Science of Infection, Testing, and Treatment

Monday, May 11, 2020 - Understanding the infection, scaling testing capabilities, and finding better treatments will end this crisis. Listen to Dr. Srivastava answer questions related to all three.

Listen Now!

Listen wherever you get your podcasts.

Stay in the Know

Get notified on updates, new episodes, and announcements.

Deepak Srivastava is president of Gladstone Institutes. He is also the Younger Family Professor and a senior investigator at the Gladstone Institute of Cardiovascular Disease and director of the Roddenberry Stem Cell Center. At UC San Francisco (UCSF), Srivastava is a professor in the departments of pediatrics and biochemistry and biophysics. Today, he discusses novel approaches to COVID-19 diagnostic testing, treatments, and prevention.

Dr. Srivastava dives right into the three key components of the COVID-19 pandemic that will affect how we move forward. He maintains that chief among those components - testing, treatment, and prevention via vaccine - is the improvement needed to diagnostic testing. By moving from the current method of lab testing, which is expensive and tests by amplifying viral genomes, to a test done in real time, we can begin reopening businesses and resuming a sense of normalcy. One possibility he suggests is the work being done by a virologist at the Gladstone Institute using CRISPR technology and enabling a smartphone camera to operate as a microscope, eliminating the need to amplify genomes and send every test to a lab for results.

Go to NoLabels.org to learn more about how we are bringing together a bipartisan group of public and private leaders working to stop the virus, save lives and get Americans back to work.

Wherever You Listen to Podcasts